Merck to Acquire Prometheus Biosciences Inc.

Start Date:4/17/2023

Start Time:8:00 AM EDT

Duration:60 minutes

If you're already registered for the Merck to Acquire Prometheus Biosciences Inc. webcast, click below:

Speakers

Rob Davis

Chairman and Chief Executive Officer

Dr. Dean Y. Li

President, Merck Research Laboratories

Dr. Eliav Barr, MD

SVP, Head of Global Clinical Development & Chief Medical Officer

Chirfi Guindo

Chief Marketing Officer, Human Health

Caroline Litchfield

Chief Financial Officer

Dr. Aileen Pangan

VP, Late-Stage Immunology

Peter Dannenbaum

VP, Investor Relations

First Name
Last Name
Email Address (no spaces)
Time Zone
By submitting this form, you are accepting the Privacy Statement.